Mini Review
Volume 6 Issue 2 - 2020
Important Considerations in the Pharmacological Management of Osteoarthritis-Related Pain
Flaminia Coluzzi1* and Stefano Gumina2
1Department Medical and Surgical Sciences and Biotechnologies, Sapienza University of Rome, Polo Pontino, Latina, Italy
2Department of Anatomy, Histology, Legal Medicine and Orthopaedics, Sapienza University of Rome, Rome, Italy
*Corresponding Author: Flaminia Coluzzi, Professor, Department Medical and Surgical Sciences and Biotechnologies, Unit Anesthesia, Intensive Care and Pain Medicine, Sapienza University of Rome, Polo Pontino, Latina, Italy.
Received: December 17, 2019; Published: January 30, 2020


In the last years, the approach to chronic osteoarthritis pain has moved from a joint-centred viewpoint towards a whole body-based approach, where the central nervous system seems to play a key role in maintaining and amplifying pain pathways. Current therapeutic strategies and future perspectives are discussed in the light of the last clinical evidence. Three targets of treatment must be considered: a) peripheral mechanisms of pain and inflammation; b) central sensitization; and c) joint degeneration. Non-pharmacological strategies are currently the first step of treatment. Among analgesics anti-inflammatory drugs and paracetamol should be preferred, and tramadol added in non-responder. Opioids, despite their efficacy, are currently not recommended for the fear of their abuse potential. Viscosupplementation via intra-articular hyaluronic acid, platelet rich plasma, and mesenchymal stem cells play a role in targeting joint pathology and prevent further damage. Targeted therapy with monoclonal antibodies may represent a viable future option for osteoarthritis and chronic low back pain, but regardless to their efficacy, further clinical studies are evaluating their safety profile before introduction on the market. Similarly, preliminary promising results coming from other biological intra-articular therapies, targeting cartilage anabolism, prevention of cartilage degradation, and subchondral bone changes, need further clinical investigations to be confirmed.

Keywords: Neuroplasticity; Chronic Pain; Monoclonal Antibodies; Osteoarthritis; Low Back Pain; Opioids


  1. Malfait AM and Miller RJ. “Emerging Targets for the Management of Osteoarthritis Pain”. Current Osteoporosis Reports 14.6 (2016): 260-268.
  2. Gumina S., et al. “The impact of aging on rotator cuff tear size”. Musculoskeletal Surgery 97.1 (2013): 69-72. 
  3. Morlion B., et al. “Pain chronification: what should a non-pain medicine specialist know?” Current Medical Research and Opinion 34.7 (2018): 1169-1178.
  4. Ji RR., et al. “Neuroinflammation and Central Sensitization in Chronic and Widespread Pain”. Anesthesiology 129.2 (2018): 343-366. 
  5. Coluzzi F., et al. “From acute to chronic pain: tapentadol in the progressive stages of this disease entity”. European Review for Medical and Pharmacological Sciences 21.7 (2017): 1672-1683. 
  6. Thakur M., et al. “Osteoarthritis pain: nociceptive or neuropathic?”. Nature Reviews Rheumatology 10.6 (2014): 374-380. 
  7. Caraci F., et al. “Modulation of sensitization processes in the management of pain and the importance of descending pathways: a role for tapentadol?”. Current Medical Research and Opinion 11 (2019): 1.
  8. Coluzzi F. "I am in pain": is it really the magic formula to open the door of opioid abuse?”. Minerva Anestesiologica 83.12 (2017): 1332-1333.
  9. McAlindon TE., et al. “OARSI guidelines for the non-surgical management of knee osteoarthritis”. Osteoarthritis Cartilage 22.3 (2014): 363-388.
  10. Pelletier JP., et al. “Efficacy and safety of oral NSAIDs and analgesics in the management of osteoarthritis: Evidence from real-life setting trials and surveys”. Seminars in Arthritis and Rheumatism 45.4 (2016): S22-S27.
  11. Bannuru RR., et al. “OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis”. Osteoarthritis Cartilage 27.11 (2019): 1578-1589.
  12. Krebs EE., et al. “Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial”. The Journal of the American Medical Association 319.9 (2018): 872-882. 
  13. Rinonapoli G., et al. “Tapentadol in the treatment of osteoarthritis: pharmacological rationale and clinical evidence”. Journal of Pain Research 12 (2019): 1529-1536.
  14. Coluzzi F., et al. “Tapentadol: an effective option for the treatment of back pain”. Journal of Pain Research 12 (2019): 1521-1528.
  15. Billeci D and Coluzzi F. “Tapentadol extended release for the management of chronic neck pain”. Journal of Pain Research 10 (2017): 495-505.
  16. Kucharz EJ., et al. “Endorsement by Central European experts of the revised ESCEO algorithm for the management of knee osteoarthritis”. Rheumatology International 39.7 (2019): 1117-1123.
  17. Pergolizzi JV., et al. “Gabapentinoid Use Disorder: Update for Clinicians”. EC Anaesthesia 4.8 (2018): 303-317.
  18. Concoff A., et al. “The efficacy of multiple versus single hyaluronic acid injections: a systematic review and meta-analysis”. BMC Musculoskeletal Disorders 18.1 (2017): 542.
  19. Le ADK., et al. “Current Clinical Recommendations for Use of Platelet-Rich Plasma”. Current Reviews in Musculoskeletal Medicine 11.4 (2018): 624-634.
  20. “Platelet-rich plasma injections for knee osteoarthritis. NICE guidelines” (2019).
  21. Delanois RE., et al. “Biologic Therapies for the Treatment of Knee Osteoarthritis”. The Journal of Arthroplasty 34.4 (2019): 801-813.
  22. Honvo G., et al. “Safety of Symptomatic Slow-Acting Drugs for Osteoarthritis: Outcomes of a Systematic Review and Meta-Analysis”. Drugs Aging 36.1 (2019): 65-99.
  23. Hunter DJ., et al. “Osteoarthritis”. Lancet 393.10182 (2019): 1745-1759.
  24. Schmelz M., et al. “Nerve-growth-factor antibody for the treatment of osteoarthritis pain and chronic low back pain: mechanism of action in the context of efficacy and safety”. Pain (2019). 
  25. Schnitzer TJ., et al. “Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients with Osteoarthritis of the Hip or Knee: A Randomized Clinical Trial”. Journal of American Medicine Association 2 322.1 (2019): 37-48.
  26. Wu Y., et al. “Novel treatments for osteoarthritis: an update”. Open Access Rheumatology 10 (2018): 135-140.
  27. Sun MM., et al. “Recent developments in emerging therapeutic targets of osteoarthritis”. Current Opinion Rheumatology 29 (2017): 96-102.
  28. Brown S., et al. “Intra-articular targeting of nanomaterials for the treatment of osteoarthritis”. Acta Biomaterialia 93.15 (2019): 239-257.
Citation: Flaminia Coluzzi and Stefano Gumina. “Important Considerations in the Pharmacological Management of Osteoarthritis-Related Pain”. EC Anaesthesia 6.2 (2020): 01-06.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

November Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the November issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for Upcoming Issue

ECronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before December 15, 2022.

Certificate of Publication

ECronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

ECronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.